Cytokines, released by TAMs, can also activate signaling pathways, involved in proliferation and chemotherapy resistance in cancer cells: TAM-derived CCL5 induced activation of signaling pathway STAT3/Nanog in prostate cancer cells, which was related with enhanced resistance to paclitaxel. The gene discussed is STAT3; the disease is prostate carcinoma.